SCHEMBL30439720

SCHEMBL30439720

COC(=O)c1cc(OC)c(OCc2ccc(F)cc2)cn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPC6 Q9Y210 2/20 0.55
MAPT P10636 4/20 0.48
FFAR4 Q5NUL3 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP3A4 P08684 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
FFAR1 O14842 1/20 0.48
KDM5A P29375 1/20 0.47
KDM5B Q9UGL1 1/20 0.47
PLA2G1B P04054 1/20 0.47
ATG4B Q9Y4P1 1/20 0.47
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
NOX1 Q9Y5S8 1/20 0.45
GAA P10253 1/20 0.45
MAPK1 P28482 1/20 0.45
RAB9A P51151 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045835 1.00 TRPC6 (0.55) TRPC6MAPTFFAR4CYP1A2CYP2C9
SCHEMBL23047422 0.89 TRPC6 (0.52) TRPC6MAPTFFAR4CYP1A2CYP2C9
SCHEMBL21045916 0.88 TRPC6 (0.56) TRPC6FFAR4FFAR1KDM5AKDM5B
SCHEMBL5806655 0.87 TRPC6 (0.53) TRPC6MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL15776567 0.86 CNR2 (0.55) TRPC6MAPTFFAR4KDM5AKDM5B
SCHEMBL17129495 0.85 ALDH1A1 (0.46) TRPC6MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL30440180 0.80 TRPC6 (0.56) TRPC6MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL21045812 0.80 TRPC6 (0.56) TRPC6MAPTCYP1A2CYP2C9CYP2C19
SCHEMBL21045659 0.78 TRPC6 (0.48) TRPC6MAPTCYP1A2CYP2C19CYP3A4
SCHEMBL21274211 0.77 SLC6A4 (0.48) SMN1; SMN2ALDH1A1MAPK1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111527078-B Pyridinecarbonyl derivatives and their therapeutic use as TRPC6 inhibitors 勃林格殷格翰国际公司 2023-06-02 CN disclosed